Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group
Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773)
03/2014
03/26/2014CN103664908A Aminopyrimidine heterocyclic compound having adenosine receptor antagonizing activity
03/26/2014CN103664897A Dihydropyrimidine compounds and application thereof in medicines
03/26/2014CN103664802A Quinazoline analogs as receptor tyrosine kinase inhibitors
03/26/2014CN103664749A Condensed-cyclic compound and organic light-emitting diode including the condensed-cyclic compound
03/26/2014CN102584810B Benzothiazole ketone compound and application thereof
03/26/2014CN102190656B Oxazolidinone bacteriophage containing azaheterocycle
03/26/2014CN101715442B Heterocyclic aspartyl protease inhibitors
03/26/2014CN101426766B Novel heteroaryl-substituted arylaminopyridine derivatives as MEK inhibitors
03/26/2014CA2828529A1 Azo compound, aqueous solution, ink composition, ink for inkjet recording, inkjet recording method, ink cartridge for inkjet recording, and inkjet recorded material
03/25/2014US8680278 Enantioselective process for preparing a substituted alkanoic acid
03/25/2014US8680126 Fluorinated thiazoles for use in treating cancer
03/25/2014US8680119 Ethers, secondary amines and derivatives thereof as modulators of the 5-HT2A serotonin receptor useful for the treatment of disorders related thereto
03/25/2014US8680118 Therapeutic agents useful for treating pain
03/25/2014US8680115 Tetrahydroquinoline analogues as muscarinic agonists
03/25/2014US8680104 Piperazinylpiperidine derivatives as chemokine receptor antagonists
03/25/2014US8680103 Process for preparing 2-aminothiazole-5-aromatic carboxamides as kinase inhibitors
03/25/2014US8680091 6-arylalkylamino-2,3,4,5-tetrahydro-1H-benzo[d]azepines as 5-HT2C receptor agonists
03/25/2014US8680090 Sulfonyl containing benzothiazole inhibitors of endothelial lipase
03/25/2014CA2620688C Heterocyclic compound
03/25/2014CA2594418C N-(heteroaryl)-1h-indole-2-carb0xamide derivatives and their use as vanilloid trpv1 receptor ligands
03/25/2014CA2531020C Cannabinoid receptor modulator
03/25/2014CA2527174C Benzothiazole derivatives and use thereof in the treatment of diseases related to the adenosine a2a receptor
03/20/2014WO2014042939A1 Ketone linked benzothiazole inhibitors of endothelial lipase
03/20/2014WO2014042263A1 Novel renin inhibitor
03/20/2014WO2014041007A1 Pyrazole carboxamide derivatives as taar modulators for use in the treatment of several disorders, such as depression, diabetes and parkinson's disease
03/20/2014WO2014040938A1 Non-annulated thiophenylamides as inhibitors of fatty acid binding proteini(fabp) 4 and/or 5
03/20/2014WO2014040572A1 Insect-resistance inducing effect and use of benzothiadiazole derivative
03/20/2014WO2014040549A1 Alkynyl heteroaromatic ring compound and application thereof
03/20/2014WO2014040243A1 N-substituted phenyl-n'-substituted heterocyclic urea compound and application thereof as anticancer medicament
03/20/2014US20140081027 Fungicidal azocyclic amides
03/20/2014US20140080851 Benzene Sulfonamide Thiazole and Oxazole Compounds
03/20/2014US20140080840 Thiazolamine Derivative and Use Thereof as Anti-Picornaviral Infection Medicament
03/20/2014US20140080835 Quinazolinone derivatives as parp inhibitors
03/20/2014US20140080828 Imidazolyl amide compounds and uses related thereto
03/20/2014US20140080825 Modulators of ATP-binding cassette transporters
03/20/2014US20140080805 Pyrrolidine inhibitors of iap
03/20/2014US20140080803 Novel trpv3 modulators
03/20/2014US20140080801 Pyrazol-4-yl-heterocyclyl-carboxamide compounds and methods of use
03/20/2014US20140080799 Aminopyrimidine Kinase Inhibitors
03/20/2014US20140080788 Novel bicyclic nitrogen containing heteroaryl tgr5 receptor modulators
03/20/2014US20140080780 identification of compounds that disperse tdp-43 inclusions
03/20/2014US20140080770 Arylalkylamine compound and process for preparing the same
03/20/2014US20140079667 Tetrazolones as inhibitors of fatty acid synthase
03/20/2014US20140076726 Detection of Immobilized Nucleic Acid
03/19/2014EP2708534A1 Thiazole compound and preparation method and use thereof
03/19/2014EP2707361A1 Fused heterocyclic compounds as sodium channel modulators
03/19/2014CN103649083A Cyclopropyl-fused-1,3-thiazepines as BACE 1 and/or BACE 2 inhibitors
03/19/2014CN103649082A Pyridine derivative and bace-1 inhibitor containing same
03/19/2014CN103649079A Hepatitis C inhibitors and uses thereof
03/19/2014CN103649077A Sulphonamide derivatives of alicyclic amines for the treatment of central nervous system diseases
03/19/2014CN103649076A Pyrrolidinyl urea and pyrrolidinyl thiourea compounds as trka kinase inhibitors
03/19/2014CN103649074A Substituted azaheterocycles for the treatment of cancer
03/19/2014CN103649062A Piperazine thiazole derivatives useful in the treatment of tauopathies such as alzheimer's disease
03/19/2014CN103649056A Fused heterocyclic compounds as sodium channel modulators
03/19/2014CN103649055A Method for manufacturing pyrazole derivative
03/19/2014CN103649053A Aminomethyl quinolone compounds
03/19/2014CN103641826A Pesticides and uses thereof
03/19/2014CN103641825A Naphthalimide derivative and application thereof as enzyme inhibitor and pesticide
03/19/2014CN103641824A Furan ring-containing 2,5-disubstituted-1,3,4-thiadiazole compound as well as preparation method and application thereof
03/19/2014CN103641823A Inhibitors of diacylglycerol O-acyltransferase type 1 enzyme
03/19/2014CN101754965B CSF-1R inhibitors, compositions, and methods of use
03/18/2014US8674113 Compounds
03/18/2014US8674112 Polymorph of a pharmaceutical
03/18/2014US8674111 Oxazole and thiazole derivatives as ALX receptor agonists
03/18/2014US8674106 Alkynyl derivatives as modulators of metabotropic glutamate receptors
03/18/2014US8674100 Inhibitors of C-FMS kinase
03/18/2014US8673942 Fused ring compounds and use thereof
03/18/2014US8673911 Inhibitors of histone deacetylase
03/18/2014US8673894 2,5,6,7-tetrahydro-[1,4]oxazepin-3-ylamine or 2,3,6,7-tetrahydro-[1,4]oxazepin-5-ylamine compounds
03/18/2014US8673891 Aminopyrazine derivative and medicine
03/18/2014CA2780682C 1-heterodiene derivative and pest control agent
03/18/2014CA2749174C Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
03/18/2014CA2700526C New compounds as adenosine a1 receptor antagonists
03/18/2014CA2637590C Treatment of inflammatory disorders with triazole compounds
03/18/2014CA2619039C 1-acyldihydropyrazole derivatives
03/13/2014WO2014039769A1 Imidazolin-5-one derivatives useful as fatty acid snthase (fasn) inhibitors for|the treatment of cancer
03/13/2014WO2014039412A1 Pyrrolone or pyrrolidinone melanin concentrating hormone receptor-1 antagonists
03/13/2014WO2014037886A1 Process for the preparation of lurasidone hydrochloride
03/13/2014WO2014037751A1 Pharmacologically active compounds
03/13/2014WO2014037480A1 6-amino acid heteroaryldihydropyrimidines for the treatment and prophylaxis of hepatitis b virus infection
03/13/2014WO2014037327A1 N-cyclopropyl-n-piperidinyl-amides, pharmaceutical compositions containing them, and uses thereof
03/13/2014US20140073797 Processes for the preparation of 2-fluoro 6-11 bicyclic erythromycin derivatives
03/13/2014US20140073676 Bicyclic compound and use thereof for medical purposes
03/13/2014US20140073661 Heterocyclic compounds and uses thereof
03/13/2014US20140073648 Methods for treating immunologic disease using aminothiazole-based inhibitor of myd88
03/13/2014US20140073640 Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases
03/13/2014US20140073639 Inhibition of antimicrobial targets with reduced potential for resistance
03/13/2014US20140073636 Novel hydroxy-6-heteroarylphenanthridines and their use as pde4 inhibitors
03/13/2014US20140073634 Heterocyclic modulators of hif activity for treatment of disease
03/13/2014US20140073632 Treating protein folding disorders with small molecule cftr correctors
03/13/2014US20140073624 Biaryl Heterocyclic Compounds and Methods of Making and Using the Same
03/13/2014US20140073622 Imidazole carbonyl compound
03/13/2014US20140072995 Modulators of ATP-Binding Cassette Transporters
03/13/2014US20140072532 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
03/13/2014DE102010062810B4 2-(R2-Thio)-10-[3-(4-R1-piperazin-1-yl)propyl]-10H-phenothiazine zur Behandlung neurodegenerativer Erkrankungen ausgewählt aus beta-Amyloidopathien und alpha-Synucleinopathien 2- (R2-thio) -10- [3- (4-R1-piperazin-1-yl) propyl] -10H-phenothiazine for the treatment of neurodegenerative diseases selected from beta-Amyloidopathien and alpha-synucleinopathies
03/12/2014EP2704713A1 Csf-1r inhibitors for treatment of brain tumors
03/12/2014CN103627147A Organic semiconductor material and thin-film transistor
03/12/2014CN103626752A Dihydropyrimidine compounds and application of same in drugs
03/12/2014CN103626751A Thiadiazole compound containing pyridine, and preparation method and application of thiadiazole compound containing pyridine
03/12/2014CN103626750A High-purity arotinolol hydrochloride and preparation method thereof
1 ... 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33 34 ... 628